Literature DB >> 7634533

Association of HincII RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives.

R Y Zee1, A P Schrader, B G Robinson, L R Griffiths, B J Morris.   

Abstract

Obese (BMI > or = 26 kg/m2; n = 51) and lean (BMI < 26 kg/m2; n = 61) Caucasian patients with severe, familial essential hypertension, were compared with respect to genotype and allele frequencies of a HincII RFLP of the low density lipoprotein receptor gene (LDLR). A similar analysis was performed in obese (n = 28) and lean (n = 68) normotensives. A significant association of the C allele of the T-->C variant responsible for this RFLP was seen with obesity (chi 2 = 4.6, P = 0.029) in the hypertensive, but not in the normotensive, group (odds ratio = 3.0 for the CC genotype and 2.7 for CT). Furthermore, BMI tracked with genotypes of this allele in the hypertensives (P = 0.046). No significant genotypic relationship was apparent for plasma lipids. Significant linkage disequilibrium was, moreover, noted between the HincII RFLP and an ApaLI RFLP (chi 2 = 33, P < 0.0005) that has previously shown even stronger association with obesity (odds ratio 19.6 for cases homozygous for the susceptibility allele and 15.2 for heterozygotes). The present study therefore adds to our previous evidence implicating LDLR as a locus for obesity in patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634533     DOI: 10.1111/j.1399-0004.1995.tb03942.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.

Authors:  Mazen Naga; Mona Amin; Dina Algendy; Ahmed Elbadry; May Fawzi; Ayman Foda; Serag Esmat; Dina Sabry; Laila Rashed; Samia Gabal; Manal Kamal
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels.

Authors:  Rui-Xing Yin; Dong-Feng Wu; Lin Miao; Lynn Htet Htet Aung; Xiao-Li Cao; Ting-Ting Yan; Xing-Jiang Long; Wan-Ying Liu; Lin Zhang; Meng Li
Journal:  Cardiovasc Diabetol       Date:  2012-10-08       Impact factor: 9.951

3.  Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants.

Authors:  Anke Hinney; Thuy Trang Nguyen; André Scherag; Susann Friedel; Günter Brönner; Timo Dirk Müller; Harald Grallert; Thomas Illig; H-Erich Wichmann; Winfried Rief; Helmut Schäfer; Johannes Hebebrand
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.